Fineotex Chemical Limited (FCL) AI Stock Analysis

• Market Cap: ₹24.85B
• Dividend Yield: 0.65%
• Average Volume (3M): 239.10K
• Price to Earnings (P/E): 23.7
• Beta (1Y): 1.25
• Revenue Growth: -10.12%
• EPS Growth: -22.38%
• Country: IN
• Employees: 205
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 0.26
• Shares Outstanding: 1,145,750,900
• 10 Day Avg. Volume: 23,734
• 30 Day Avg. Volume: 239,105
• PEG Ratio: -0.21
• Price to Book (P/B): 0.37
• Price to Sales (P/S): 0.50
• P/FCF Ratio: -36.65
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.9
• Revenue Forecast (FY): ₹5.67B

• Rating: 75 Outperform
• Price Target: ₹24.50 ▲(0.04% Upside)
• Action: Upgraded Date: 11/07/25
• Date: Action: Upgraded 11/07/25

Fineotex Chemical Limited's strong financial performance is the primary driver of its stock score, supported by stable profitability and growth metrics. Technical analysis suggests a neutral trend with potential bullish momentum. The valuation indicates moderate overvaluation, which slightly tempers the overall score.

Positive Factors

Consistent revenue growth and resilient top-line

Sustained revenue expansion over multiple years indicates durable demand for Fineotex's specialty chemical formulations. Recurring purchases from textile processors and technical application support help stabilize volumes and create a repeatable revenue base that supports growth over the next 2-6 months.

High and stable gross and improving net margins

Consistently strong gross margins above 30% reflect differentiated, value-added formulations and pricing power. Improving net margins signal effective cost control and operating leverage, supporting sustainable profitability even if volumes fluctuate across cycles over the medium term.

Healthy balance sheet with low leverage

Low debt and a strong equity ratio provide financial flexibility to fund capex or working capital needs without stressing liquidity. This conservative capital structure reduces refinancing risk and supports continued operations and strategic investment over the coming months.

Negative Factors

Variable free cash flow and rising capital expenditures

Declining free cash flow driven by higher capex reduces near-term liquidity and increases reliance on internal cash generation. If investment levels remain elevated, cash reserves and flexibility could be pressured, constraining discretionary spending or dividend capacity over the medium term.

Negative recent EPS growth trend

A negative EPS growth rate signals earnings per share pressure despite revenue and margin strengths. Persistent EPS decline can limit ability to fund shareholder returns and may indicate operational or non-recurring factors that could weigh on reported profitability in the coming quarters.

Concentration in textile processing end-market

Heavy reliance on textile and garment processors exposes revenue to sector cyclicality, regional demand swings, and volume-driven variability. Structural exposure to one primary industry can amplify revenue and margin volatility if textile production weakens over the next several months.

Fineotex Chemical Limited Business Overview & Revenue Model

Company Description

Fineotex Chemical Limited manufactures and sells textile chemicals, and auxiliary and specialty chemicals in India and internationally. The company provides specialty textile chemicals for pretreatment, dyeing, printing, and finishing processes; water treatment chemicals, paper adhesives, and defoamers; various chemicals, such as benzalkonium chloride (BKC), barite, hematite, magnesium chloride, and calcium chloride; water-based drilling fluid chemicals, including clay/shale inhibitors, lubricants, specialty chemicals, spotting fluids, and loss circulation additives, as well as oil-based drilling fluid chemicals. It also offers cleaning, and hygiene products comprising liquid detergents, surface and hand disinfectants, sanitizing tablets, hand sanitizers and wash liquids, multi surface disinfectant liquids, and air fresheners; and white phenyl and detergent cakes. The company's products are used in textile, home care, hygiene, mining, garment, water treatment, leather, construction, paint, agrochemicals, and adhesives sectors. Fineotex Chemical Limited was founded in 1979 and is headquartered in Mumbai, India.

How the Company Makes Money

FCL makes money primarily by selling specialty chemical products and process auxiliaries to industrial customers, with revenue recognized from the supply of these chemical formulations for use in textile processing operations (e.g., chemicals used across pretreatment, dyeing/printing, and finishing stages). Its revenue model is largely volume- and mix-driven: customer consumption depends on textile production throughput, the range of processes performed, and the performance requirements (which influence which formulations are purchased and at what margins). In addition to product sales, recurring earnings are typically supported by repeat purchases tied to ongoing production runs and by providing technical service/application guidance that helps customers optimize processes and standardize on specific formulations. Specific details on segment-wise revenue split, pricing structure, contract terms, or material partnerships are null.

Fineotex Chemical Limited Financial Statement Overview

Summary

Fineotex Chemical Limited exhibits strong financial health with robust revenue growth, solid profitability, and a stable balance sheet characterized by low leverage. However, recent fluctuations in cash flow due to increased capital expenditures suggest a need for careful cash management.

Income Statement

Fineotex Chemical Limited has demonstrated robust revenue growth with a significant increase from 2020 to 2025. The company maintained a strong gross profit margin, consistently above 30%, and an improving net profit margin, indicating efficient cost management. Despite a slight dip in revenue in the latest year, the overall performance showcases resilience and profitability, making the income statement solid.

Balance Sheet

The balance sheet of Fineotex Chemical Limited reflects a healthy financial position with low debt levels and a growing stockholders' equity, resulting in a very low debt-to-equity ratio. The equity ratio remains strong, highlighting financial stability. However, the lower cash reserves in the latest year could pose a risk if not managed carefully.

Cash Flow

Cash flow analysis shows variability, with a recent decline in free cash flow due to increased capital expenditures. The operating cash flow to net income ratio indicates strong cash generation capabilities, although the fluctuation in free cash flow suggests potential liquidity challenges if investment activities continue to rise.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	5.20B	5.33B	5.69B	5.17B	3.67B	2.17B
Gross Profit	1.94B	2.06B	2.17B	1.78B	1.30B	757.73M
EBITDA	1.41B	1.52B	1.65B	1.13B	767.24M	580.62M
Net Income	984.00M	1.08B	1.20B	883.16M	551.74M	425.88M
Balance Sheet
Total Assets	8.78B	8.15B	5.48B	4.22B	3.39B	2.67B
Cash, Cash Equivalents and Short-Term Investments	640.69M	330.01M	735.06M	611.90M	308.35M	279.33M
Total Debt	297.00K	2.17M	51.90M	72.80M	19.08M	34.76M
Total Liabilities	898.43M	757.59M	945.90M	659.02M	700.96M	509.90M
Stockholders Equity	7.79B	7.31B	4.47B	3.49B	2.62B	2.09B
Cash Flow
Free Cash Flow	81.22M	-73.46M	494.76M	887.62M	-91.37M	-149.48M
Operating Cash Flow	200.95M	693.34M	973.81M	1.08B	133.75M	92.59M
Investing Cash Flow	-51.66M	-2.73B	-468.50M	-1.03B	-7.44M	-65.32M
Financing Cash Flow	-49.37M	1.76B	-239.11M	-64.39M	-56.59M	-44.42M

Fineotex Chemical Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 24.49
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FCL, the sentiment is Negative. The current price of 24.49 is above the 20-day moving average (MA) of 22.83, above the 50-day MA of 23.07, and below the 200-day MA of 24.72, indicating a bearish trend. The MACD of -0.51 indicates Positive momentum. The RSI at 40.49 is Neutral, neither overbought nor oversold. The STOCH value of 36.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:FCL.

Fineotex Chemical Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MANINDS	78 Outperform	₹27.97B	13.17	―	―	10.26%	46.49%
FCL	75 Outperform	₹24.85B	23.71	―	0.65%	-10.12%	-22.38%
RAMRAT	64 Neutral	₹28.66B	22.96	―	0.39%	19.75%	13.42%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
KIRIINDUS	57 Neutral	₹22.52B	0.22	―	―	-22.04%	-58.81%
MOL	46 Neutral	₹10.82B	-115.81	―	―	―	―
TIRUMALCHM	45 Neutral	₹20.97B	-15.05	―	0.43%	-11.11%	-340.74%

Fineotex Chemical Limited Corporate Events

Fineotex Chemical Shares Q3 and 9M FY26 Earnings Call Transcript

Fineotex Chemical Limited has released the transcript of its earnings conference call covering the third quarter and nine-month financial performance for FY2025-26, held with investors and analysts on 16 February 2026. The disclosure, made under SEBI listing regulations and posted on the company’s website, underscores Fineotex’s ongoing engagement with the capital markets and its commitment to transparent communication of financial results to shareholders and market participants.

Fineotex Chemical Files SEBI Demat Compliance Certificate for December 2025 Quarter

Fineotex Chemical Limited has submitted to the stock exchanges a compliance certificate from its registrar and share transfer agent, Bigshare Services Pvt. Ltd., confirming adherence to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025. The certificate states that all securities received for dematerialisation during the quarter were duly verified, either accepted or rejected, appropriately mutilated and cancelled where required, and that the depositories were recorded as the registered owners within the prescribed 15-day timeline, underscoring the company’s ongoing compliance with regulatory requirements in handling its listed securities.